Concord Medical received large medical equipment procurement license for proton therapy equipment

image credit- shutterstock

Concord Medical Services Holdings Limited, a healthcare provider specialized in cancer treatment, research, education and prevention in China, announced that Guangzhou Concord Cancer Center (Guangzhou Hospital), a PRC subsidiary of the Company offering comprehensive cancer care services, has obtained the large medical equipment procurement license for its proton equipment.

Guangzhou Hospital has previously completed the installment of the proton equipment in September 2020 and commenced its clinical trial in November 2022. Guangzhou Hospital has also subsequently submitted the application for the License for such proton equipment, planning to offer proton therapy treatment services at its proton center. On September 14, 2024, the National Health Commission of the PRC announced to grant approval to Guangzhou Hospital's application for the License. Guangzhou Hospital plans to start its proton therapy treatment services at its earliest convenience after necessary preparations.